The US Food and Drug Administration (FDA) recently issued its draft guidance, Considerations for the Use of Artificial Intelligence to ...
At a high level, the guidance underscores the FDA’s goals for establishing AI model credibility within the context of use. This article provides an overview of the guidance, including example ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback